July 2020 Issue Table Of Contents

From The Editor

• What’s With All The Stuff On Corporate Culture?

Feature Articles

• Aligos Therapeutics — The Next Step Of Lawrence Blatt’s Entrepreneurial Expedition
• Building A Digital Therapeutics Company

Capitol Perspectives

• More Nuanced Approach Needed To Fight COVID-19

CEO Corner

• Leading And Managing Change During A Time Of Transition And Cultural Transformation

Companies To Watch

• Equillium

From Policy to Execution

• Planning & Policy Making In An Era Of Uncertainty

Industry Research

• Attributes Gaining Importance In Clinical Research

Inside The Industry

• AI & The Global Data Quality Imperative
• OTC Drug Monograph Reform In The CARES Act
• Why Is Antibiotic Development In The U.S. Disappearing?
• Helping Managers Navigate Through The “New Normal”
• The Viral Startup

Industry Leader

• Realizing The Value Of Quantum Computing In Life Sciences
• How To Prepare For The Next Healthcare Crisis That We Don’t See Coming
• Virtual Marking: A Flexible Option For Pharmaceuticals

Leadership Lessons

• Thinking Entrepreneurially Inside Your Organization: How Leaders Can Drive Low-Cost Innovation

Ask The Board

• What Are Strategies Biopharmas Can Use To Educate And Influence Change Within Their Organization?
• Will The “Work-From-Home” Concept Ever Take Off In The Biopharma Industry? If Yes, What Conditions/Trends Will Enable It To Happen? If Not, What Are The Barriers Stopping The Industry From Embracing This Trend?
• How Can A Cell Therapy Manufacturer Avoid The Impact Of Supply Chain Disruptions Via Single Use Systems (SUS), While Also Being Sustainable For The Environment?

---

2020 CRO Leadership Awards

From The Editor

• DIA And CRO Leadership Awards Go Virtual

Feature Article

• The Benefits & Challenges Of Head-To-Head Trials

Industry Research

• Can CROs Rise To The Patient Access & Recruitment Challenge?

Inside The Industry

• A Quick Transition From Research Firm To Clinical-Phase Biotech
• A Small Biopharma’s View Of Working With CROs
• Transformative Reflections On The Life Science World, Post-COVID-19
• 3 Essential Considerations For Running Global Clinical Trials
• eConsent In Clinical Trials: Insights For Implementation During COVID-19 And Beyond
• 5 Bad Habits The Clinical Trial Community Needs To Break ASAP

Winners List